Topical imiquimod to treat intraepidermal carcinoma.
Hengge
U R
UR
Department of Dermatology, Venereology and Allergology, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany. ulrich.hengge@uni-essen.de
Stark
R
R
D000279:Administration, Cutaneous; D000368:Aged; D000369:Aged, 80 and over; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000517:prevention & control; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control; D005260:Female; D006801:Humans; D000077271:Imiquimod; D007642:Keratosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009666:Nose; D010787:Photosensitivity Disorders / Q000188:drug therapy* / Q000473:pathology; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013909:Thorax
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod